Edap TMS SA (EDAP)
2.59
-0.14
(-5.13%)
USD |
NASDAQ |
Nov 08, 16:00
2.59
0.00 (0.00%)
After-Hours: 17:17
Edap TMS Revenue (TTM): 67.10M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 67.10M |
March 31, 2024 | 65.66M |
December 31, 2023 | 65.36M |
September 30, 2023 | 60.31M |
June 30, 2023 | 59.87M |
March 31, 2023 | 59.37M |
December 31, 2022 | 58.06M |
September 30, 2022 | 57.97M |
June 30, 2022 | 56.77M |
March 31, 2022 | 54.17M |
December 31, 2021 | 52.00M |
September 30, 2021 | 54.34M |
June 30, 2021 | 54.24M |
March 31, 2021 | 51.96M |
December 31, 2020 | 47.94M |
September 30, 2020 | 42.90M |
June 30, 2020 | 43.33M |
March 31, 2020 | 47.16M |
December 31, 2019 | 50.27M |
September 30, 2019 | 46.47M |
June 30, 2019 | 65.12M |
March 31, 2019 | 61.37M |
December 31, 2018 | 61.11M |
September 30, 2018 | 64.14M |
June 30, 2018 | 42.41M |
Date | Value |
---|---|
March 31, 2018 | 42.39M |
December 31, 2017 | 40.39M |
September 30, 2017 | 39.41M |
June 30, 2017 | 39.95M |
March 31, 2017 | 38.96M |
December 31, 2016 | 39.35M |
September 30, 2016 | 40.71M |
June 30, 2016 | 38.91M |
March 31, 2016 | 38.31M |
December 31, 2015 | 35.70M |
September 30, 2015 | 30.89M |
June 30, 2015 | 32.92M |
March 31, 2015 | 31.99M |
December 31, 2014 | 35.61M |
September 30, 2014 | 38.53M |
June 30, 2014 | 36.74M |
March 31, 2014 | 34.90M |
December 31, 2013 | 32.09M |
September 30, 2013 | 33.30M |
June 30, 2013 | 33.03M |
March 31, 2013 | 35.01M |
December 31, 2012 | 33.53M |
September 30, 2012 | 31.44M |
June 30, 2012 | 32.99M |
March 31, 2012 | 30.59M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
42.90M
Minimum
Sep 2020
67.10M
Maximum
Jun 2024
55.20M
Average
54.34M
Median
Sep 2021
Revenue (TTM) Benchmarks
DBV Technologies SA | -- |
Genfit SA | 30.01M |
Cellectis SA | 29.07M |
Adaptimmune Therapeutics PLC | 141.46M |
Akari Therapeutics PLC | -- |